Non-Regulatory

November 19, 2013

Interim Report – January to September 2013

Affibody Medical AB (publ) (“Affibody” or “the Company”), a Swedish biotech company focused on developing next generation biopharmaceuticals based on its unique proprietary technology platforms: Affibody® molecules and Albumod™,...

Read more

Non-Regulatory

November 5, 2013

Sobi announces phase I Complement Inhibitor program

Swedish Orphan Biovitrum AB (publ) (Sobi) announced its intention to bring a novel investigational biopharmaceutical drug candidate, SOBI002, into a phase I trial today at the company’s Capital Markets...

Read more

Non-Regulatory

October 1, 2013

EU Funded Effort to Develop New Stroke Therapies

Solna, Sweden, October 1, 2013. The COUNTERSTROKE consortium led by researchers at Karolinska Institutet today initiates a six million Euro EU funded collaboration to develop novel therapeutics to treat...

Read more

Non-Regulatory

September 17, 2013

New molecular imaging agents being developed for fluorescence-guided brain cancer surgery

Solna, Sweden, September 17, 2013. Dartmouth, LI-COR and Affibody receive NIH grant for development and translation of imaging agents for fluorescence-guided surgery.

Read more

Non-Regulatory

August 29, 2013

Interim Report – January to June 2013

Affibody Medical AB (publ) (“Affibody” or “the Company”), a Swedish biotech company focused on developing next generation biopharmaceuticals based on its unique proprietary technology platforms: Affibody® molecules and Albumod™,...

Read more

Non-Regulatory

August 20, 2013

Resolutions from Affibody’s Extraordinary General Meeting (EGM)

Stockholm, Sweden, August 20, 2013. The Affibody Holding AB’s (publ) (Affibody) EGM convened earlier today in Stockholm and voted in favor of the resolutions proposed at the meeting.

Read more

Non-Regulatory

July 23, 2013

Kallelse till extra bolagsstämma

Aktieägarna i Affibody Holding AB (publ) kallas härmed till extra bolagsstämma tisdagen den 20 augusti 2013 kl 10.00 i Advokatfirman Lindahls lokaler, Mäster Samuelsgatan 20, Stockholm.

Read more

Non-Regulatory

June 28, 2013

Resolutions from Affibody’s Annual General Meeting (AGM)

Solna, Sweden, June 28, 2013. The Affibody Holding AB’s (publ) (Affibody) AGM convened earlier today in Solna and voted in favour of the resolutions proposed at the meeting,...

Read more

Non-Regulatory

June 25, 2013

Affibody AB and Daiichi Sankyo enter into a License Agreement regarding the Albumod™ platform

Solna, Sweden, June 25, 2013. Affibody is pleased to announce a collaboration with Daiichi Sankyo Company Limited (hereinafter Daiichi Sankyo; headquartered in Chuo Ward, Tokyo, TSE 4568).

Read more